Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of total sulfhydryl levels and dietary habits in pemphigus vulgaris. | Postepy Dermatol Alergol | 2025 | 40672734 | PubTator, text mining | PubMed |
| Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid. | Front Immunol | 2025 | 40661962 | PubTator, text mining | PubMed |
| Phage display-derived peptides as molecular probes for predicting Staphylococcal Exfoliative Toxin-Desmoglein 1 interactions. | Int J Biol Macromol | 2025 | 40618811 | PubTator, text mining | PubMed |
Comparison of anti-desmoglein antibodies titres and anti-M3 muscarinic acetylcholine receptor antibody titres as biomarker for potential pemphigus between subjects who are occupationally exposed and not exposed to pesticides. | Indian J Dermatol Venereol Leprol | 2025 | 40587540 | PubTator, text mining | PubMed |
| Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: a case report and literature review. | Dermatol Reports | 2025 | 40576630 | PubTator, text mining | PubMed |
| Circulating Antibodies Against DSG1 and DSG3 in Patients with Oral Lichen Planus: A Scoping Review. | Antibodies (Basel) | 2025 | 40558105 | PubTator, text mining | PubMed |
| Gene expression study in the siRNA based aniridia cell model and in primary aniridia limbal epithelial cells following duloxetine and ritanserin treatment. | PLoS One | 2025 | 40493651 | PubTator, text mining | PubMed |
| Comprehensive benchmarking of genome editing quantification methods for plant applications. | iScience | 2025 | 40487430 | PubTator, text mining | PubMed |
| Factors associated with persistent anti-desmoglein positivity after remission in pemphigus vulgaris: a prospective registry-based cohort study. | Front Immunol | 2025 | 40433384 | PubTator, text mining | PubMed |
| Autoimmune bullous diseases: pathogenesis and clinical management. | Mol Biomed | 2025 | 40372624 | PubTator, text mining | PubMed |
| A Bidirectional Two-Sample Mendelian Randomization Study of Genetic Causality Between Vitamin D Levels and Pemphigus. | Clin Cosmet Investig Dermatol | 2025 | 40370580 | PubTator, text mining | PubMed |
| Discovery of new protein partners of anterior gradient 2 (AGR2) from cell-cell adhesion pathway using genetically-encoded photo-crosslinker DiZPK. | Bioorg Med Chem | 2025 | 40367911 | PubTator, text mining | PubMed |
| Synergistic Enhancement of Compromised Skin Radiance: A Clinical Investigation of Prinsepia utilis Royle Polysaccharides and Nonapeptide Co-Application. | J Cosmet Dermatol | 2025 | 40367144 | PubTator, text mining | PubMed |
| Loss-of-function variants in DUSP1 encoding dual specificity phosphatase 1 cause palmoplantar keratoderma. | Br J Dermatol | 2025 | 40359362 | PubTator, text mining | PubMed |
| Blocking of IL-4/IL-13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome. | Exp Dermatol | 2025 | 40344324 | PubTator, text mining | PubMed |
| Effect of isolated keratin 3 knockdown on gene expression of primary limbal epithelial cells without and with inflammatory stimuli. | Ann Anat | 2025 | 40334825 | PubTator, text mining | PubMed |
| DSG2 attenuates gemcitabine efficacy through PTX3 in lung adenocarcinoma. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40316058 | PubTator, text mining | PubMed |
| The Overlap of Allergic Disorders and Upper Gastrointestinal Symptoms: Beyond Eosinophilic Esophagitis. | Nutrients | 2025 | 40284218 | PubTator, text mining | PubMed |
| Complete Resolution of Atypical Paraneoplastic Pemphigus Following Treatment With Dupilumab. | Cureus | 2025 | 40264631 | PubTator, text mining | PubMed |
| Direct inhibition precedes p38 mitogen activated protein kinase-mediated uncoupling in desmosomes to reduce desmoglein 3 adhesion by pemphigus autoantibodies. | Br J Dermatol | 2025 | 40264374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=6